Table 1: : Overview of the substrates administered per day during the 4-week treatment periods in the different groups

From: Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities

 Treatment period 1Treatment period 2Treatment period 3Treatment period 4
Group 1 (n=11)2 × 10 g lactulose+2 × 250 mg placebo S. boulardii2 × 10 g placebo lactulose+2 × 250 mg placebo S. boulardii2 × 10 g placebo lactulose+2 × 250 mg S. boulardii 
Group 2 (n=11)2 × 15 g lactulose+4 × 250 mg placebo S. boulardii2 × 15 g placebo lactulose+4 × 250 mg placebo S. boulardii2 × 15 g placebo lactulose+4 × 250 mg S. boulardii 
Group 3 (n=11)2 × 10 g lactulose+2 × 250 mg placebo S. boulardii2 × 10 g lactulose+2 × 250 mg S. boulardii2 × 10 g placebo lactulose+2 × 250 mg S. boulardii 
Group 4 (n=10)2 × 109 B. breve+2 × 10 g placebo OF-IN2 × placebo B. breve+2 × 10 g OF-IN2 × placebo B. breve+2 × 10 g placebo OF-IN 
Group 5 (n=10)2 × 6.5 × 109 L. casei Shirota+2 × 10 g placebo OF-IN2 × placebo L. casei Shirota+2 × 10 g OF-IN2 × placebo L. casei Shirota+2 × 10 g placebo OF-IN2 × 6.5 × 109 L. casei Shirota+2 × 10 g OF-IN
  1. Abbreviations: B. breve, Bifidobacterium breve; L. casei, Lactobacillus casei; OF-IN, oligofructose-enriched inulin; S. boulardii, Saccharomyces boulardii.